TY - JOUR
T1 - Prompt administration of antibiotics and fluids in the treatment of sepsis
T2 - A murine trial
AU - Lewis, Anthony J.
AU - Griepentrog, John E.
AU - Zhang, Xianghong
AU - Angus, Derek C.
AU - Seymour, Christopher W.
AU - Rosengart, Matthew R.
N1 - Funding Information:
Supported, in part, by a Basic/Translational Research Training Fellowship Grant awarded by the Surgical Infection Society (to Dr. Rosengart), R01 GM082852 (to Dr. Rosengart), R01 GM116929 (to Dr. Rosengart), T32GM008516 (to Dr. Lewis), and R35GM119519 (to Dr. Seymour) from the National Institutes of Health.
Funding Information:
R01 GM082852 (to Dr. Rosengart), R01 GM116929 (to Dr. Rosengart), ship Grant awarded by the Surgical Infection Society (to Dr. Rosengart), Sepsis is common and deadly (1–4). In the United States T32GM008516 (to Dr. Lewis), and R35GM119519 (to Dr. Seymour) alone, more than 1 million patients are hospitalized from the National Institutes of Health. with sepsis annually, and sepsis accounts for nearly one port for article research from the National Institutes of Health (NIH). Dr. Drs. Lewis, Griepentrog, Zhang, Seymour, and Rosengart received sup- of every two hospital deaths (1–4). Despite advances in our Seymour’s institution received funding from NIH National Institute of understanding of the complex biology of sepsis, many preci-General Medical Sciences, and he received funding from Beckman Coul- sion approaches to sepsis, including biologic therapeutics, have potential conflicts of interest.ter and Edwards. Dr. Angus has disclosed that he does not have any not meaningfully improved outcomes in randomized clinical For information regarding this article, E-mail: [email protected] trials (5). Thus, the cornerstones of treatment remain antibiot-Copyright © 2018 by the Society of Critical Care Medicine and Wolters ics, resuscitation with IV fluids, and provision when needed Kluwer Health, Inc. All Rights Reserved. of vital organ support, such as vasopressors and mechanical DOI: 10.1097/CCM.0000000000003004 ventilation. International guidelines, large cohort studies, and
Publisher Copyright:
Copyright © 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Objectives: Sepsis, the acute organ dysfunction caused by a dysregulated host response to infection, poses a serious public health burden. Current management includes early detection, initiation of antibiotics and fluids, and source control as necessary. Although observational data suggest that delays of even a few hours in the initiation of antibiotics or IV fluids is associated with survival, these findings are controversial. There are no randomized data in humans, and prior animal studies studied time from experimental manipulation, not from the onset of clinical features of sepsis. Using a recently developed murine cecal ligation and puncture model that precisely monitors physiologic deterioration, we hypothesize that incremental hourly delays in the first dose of antibiotics, in the first bolus of fluid resuscitation, or a combination of the two at a clinically relevant point of physiologic deterioration during polymicrobial sepsis will shorten survival. Design: Randomized laboratory animal experimental trial. Setting: University basic science laboratory. Subjects: Male C57BL/6J, female C57BL/6J, aged (40-50 wk old) male C57BL/6J, and BALB/C mice. Interventions: Mice (n = 200) underwent biotelemetry-enhanced cecal ligation and puncture and were randomized after meeting validated criteria for acute physiologic deterioration. Treatment groups consisted of a single dose of imipenem/cilastatin, a single bolus of 30 mL/kg fluid resuscitation, or a combination of the two. Mice were allocated to receive treatment at the time of meeting deterioration criteria, after a 2-hour delay or after a 4-hour delay. Measurements and Main Results: Hourly delays in the initiation of antibiotic therapy led to progressively shortened survival in our model (p < 0.001). The addition of fluid resuscitation was unable to rescue animals, which received treatment 4 hours after meeting enrollment criteria. Systemic inflammation was increased, and host physiology was increasingly deranged with hourly delays to antibiotics. Conclusions: We conclude that antibiotic therapy is highly time sensitive, and efforts should be made to deliver this critical therapy as early as possible in sepsis, perhaps extending into the first point of medical contact outside the hospital.
AB - Objectives: Sepsis, the acute organ dysfunction caused by a dysregulated host response to infection, poses a serious public health burden. Current management includes early detection, initiation of antibiotics and fluids, and source control as necessary. Although observational data suggest that delays of even a few hours in the initiation of antibiotics or IV fluids is associated with survival, these findings are controversial. There are no randomized data in humans, and prior animal studies studied time from experimental manipulation, not from the onset of clinical features of sepsis. Using a recently developed murine cecal ligation and puncture model that precisely monitors physiologic deterioration, we hypothesize that incremental hourly delays in the first dose of antibiotics, in the first bolus of fluid resuscitation, or a combination of the two at a clinically relevant point of physiologic deterioration during polymicrobial sepsis will shorten survival. Design: Randomized laboratory animal experimental trial. Setting: University basic science laboratory. Subjects: Male C57BL/6J, female C57BL/6J, aged (40-50 wk old) male C57BL/6J, and BALB/C mice. Interventions: Mice (n = 200) underwent biotelemetry-enhanced cecal ligation and puncture and were randomized after meeting validated criteria for acute physiologic deterioration. Treatment groups consisted of a single dose of imipenem/cilastatin, a single bolus of 30 mL/kg fluid resuscitation, or a combination of the two. Mice were allocated to receive treatment at the time of meeting deterioration criteria, after a 2-hour delay or after a 4-hour delay. Measurements and Main Results: Hourly delays in the initiation of antibiotic therapy led to progressively shortened survival in our model (p < 0.001). The addition of fluid resuscitation was unable to rescue animals, which received treatment 4 hours after meeting enrollment criteria. Systemic inflammation was increased, and host physiology was increasingly deranged with hourly delays to antibiotics. Conclusions: We conclude that antibiotic therapy is highly time sensitive, and efforts should be made to deliver this critical therapy as early as possible in sepsis, perhaps extending into the first point of medical contact outside the hospital.
KW - animal model
KW - antibiotics
KW - resuscitation
KW - sepsis
KW - telemetry
UR - http://www.scopus.com/inward/record.url?scp=85054126488&partnerID=8YFLogxK
U2 - 10.1097/CCM.0000000000003004
DO - 10.1097/CCM.0000000000003004
M3 - Article
C2 - 29369056
AN - SCOPUS:85054126488
SN - 0090-3493
VL - 46
SP - e426-e434
JO - Critical care medicine
JF - Critical care medicine
IS - 5
ER -